MedPath

Study of predictive blood investigations in stomach cancer

Not Applicable
Conditions
Health Condition 1: C169- Malignant neoplasm of stomach, unspecified
Registration Number
CTRI/2022/04/042256
Lead Sponsor
Jawaharlal institute of postgraduate medical education and research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with age 18 years and above

and Histopathology Proven Gastric Adenocarcinoma including Junctional (Gastro-esophageal junction) tumor with or without associated barretâ??s esophagus

Exclusion Criteria

- PATIENTS WHO HAVE ALREADY RECIEVED CHEMOTHERAPY FOR ADENOCARCINOMA OF STOMACH

- PATIENTS WHO HAVE ALREADY UNDERGONE CURATIVE RESECTION FOR ADENOCARCINOMA STOMACH AND PRESENT WITH RECURRENCE

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath